Skip to main content

Intercure Ltd.

INCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001857030

No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Intercure Ltd. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of INCR: Q4 2025 compared with Q1 2026
MeasureQ4 2025Q1 2026Change
Holders1815−3
Shares721.3K602.9K−118.3K (−16.4%)
Value$796.3K$617.9K−$178.4K (−22.4%)

New holders (1)

Institutions that held Intercure Ltd. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to INCR in Q1 2026
InstitutionSharesValue% of portfolio
Virtu Financial LLC18,945$14.0K0.00%

Sold out (4)

Institutions that held Intercure Ltd. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of INCR in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
AdvisorShares Investments LLC105,944$96.4K
Jane Street Group, LLC76,805$78.0K
Bank of America Corp7,917$7.21K
Founders Capital Management7,000$6.37K